Is Planned Neck Dissection Necessary for Head and Neck Cancer After Intensity-Modulated Radiotherapy?

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 707-713

  Yao, Min ^a   Hoffman, Henry T ^a   Chang, Kristi ^a   Funk, Gerry F ^a   Smith, Russell B ^a   Tan, Huaming ^b   Clamon, Gerald H ^a   Dornfeld, Ken ^a   Buatti, John M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Head and neck cancer; IMRT; Planned neck dissection

Indexed keywords

GLUCOSE; MEDICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY; HEAD AND NECK CANCER; PLANNED NECK DISSECTION;

ONCOLOGY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CERVICAL LYMPHADENOPATHY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OUTCOME ASSESSMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249307832     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.065     Document Type: Article

References (40)

1. Barkley Jr. H.T., Fletcher G.H., Jesse R.H., et al. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 124 (1972) 462-467
2. Mendenhall W.M., Million R.R., and Cassisi N.J. Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12 (1986) 733-740
3. Grabenbauer G.G., Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only?. Radiother Oncol 66 (2003) 57-63
4. Chan A.W., Ancukiewicz M., Carballo N., et al. The role of postradiotherapy neck dissection in supraglottic carcinoma. Int J Radiat Oncol Biol Phys 50 (2001) 367-375
5. Peters L.J., Weber R.S., Morrison W.H., et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 18 (1996) 552-559
6. Clayman G.L. The current status of gene therapy. Semin Oncol 27 (2000) 39-43
7. Johnson C.R., Silverman L.N., Clay L.B., et al. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: Is postradiotherapy neck dissection necessary?. Radiat Oncol Investig 6 (1998) 52-57
8. Corry J., Rischin D., Smith J.G., et al. Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer. Radiother Oncol 54 (2000) 123-127
9. Garden A.S., Glisson B.S., Ang K.K., et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses. J Clin Oncol 17 (1999) 2390-2395
10. Brizel D.M., Prosnitz R.G., Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1418-1423
11. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
12. Mendenhall W.M., Villaret D.B., Amdur R.J., et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 24 (2002) 1012-1018
13. Pellitteri P.K., Ferlito A., Rinaldo A., et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?. Head Neck 28 (2006) 166-175
14. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
15. Yao M., Nguyen T., Buatti J.M., et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29 (2006) 606-612
16. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63 (2005) 410-421
17. Chao K.S., Ozyigit G., Tran B.N., et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
18. Lee N., Xia P., Fischbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
19. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
20. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
21. Lin A., Kim H.M., Terrell J.E., et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
22. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
23. Karnell L.H., Yao M., and Funk G.F. Quality-of-life outcomes of oropharyngeal cancer patients after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) S535-S536
24. Garden A.S., and Ang K.K. Radiotherapy for head and neck cancer: Indications and techniques. 2nd ed. (2002), Lippincott Williams & Wilkins Publishers, Philadelphia
25. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
26. Stenson K.M., Huo D., Blair E., et al. Planned post-chemoradiation neck dissection: Significance of radiation dose. Laryngoscope 116 (2006) 33-36
27. Mendenhall W.M., Parsons J.T., and Million R.R. Unnecessary irradiation of the normal larynx. Int J Radiat Oncol Biol Phys 18 (1990) 1531-1533
28. Sanguineti G., Culp L.R., Endres E.J., et al. Are neck nodal volumes drawn on CT slices covered by standard three-field technique?. Int J Radiat Oncol Biol Phys 59 (2004) 725-742
29. Yao M., Graham M.M., Smith R.B., et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: A preliminary report. Int J Radiat Oncol Biol Phys 60 (2004) 1410-1418
30. Yao M., Graham M.M., Hoffman H.T., et al. The role of postradiation therapy FDG PET in prediction of necessity for postradiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
31. Yao M, Luo P, Hoffman HT, et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol (in press).
32. Yao M., Smith R.B., Graham M.M., et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 63 (2005) 991-999
33. Rogers J.W., Greven K.M., McGuirt W.F., et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys 58 (2004) 694-697
34. Yao M., Buatti J.M., Dornfeld K.J., et al. Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer?. In regard to Rogers, et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697). Int J Radiat Oncol Biol Phys 61 (2005) 306-307 author reply 307
35. Greven K.M., Williams III D.W., McGuirt Sr. W.F., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
36. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
37. Porceddu S.V., Jarmolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
38. Brkovich V.S., Miller F.R., Karnad A.B., et al. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116 (2006) 855-858
39. Nayak J.V., Daamen N., Ferris R.L., et al. Deferring planned neck dissection after chemoradiation therapy in stage IV head and neck cancer: The utility of PET/CT. Arch Otolaryngol Head Neck Surg 132 (2006) 843
40. Yao M., Chang K., Funk G.F., et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the University of Iowa experience. Int J Radiat Oncol Biol Phys (2006) (in press)